Global miRNA Market Outlook to 2018

  • August 2014
  • -
  • RNCOS
  • -
  • 80 pages

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart Disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market Outlook to 2018”, provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.

The report covers present and future outlooks for the two broad categories of miRNA; tools and services segments. The former comprises various tools that are used to study miRNA. These include isolation kits, PCR arrays, labels, markers, mimics and inhibitors. On the other hand, the latter includes various services such as purification, expression profiling, quantification and analysis that are offered by miRNA players.

The market has been divided into three sections -The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are applied to control gene translation and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market players which are engaged in providing miRNA based tools and services. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors, and constantly upgrading their portfolio to keep up with the latest developments in the field. Some of these players include Qiagen, Life Technologies, Exiqon and Mirus Bio.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.

Table Of Contents

1. Analyst View
2. Research Methodology
3. miRNA - An Introduction
4. miRNA Techniques
4.1 miRNA Purification
4.2 miRNA Labeling
4.3 miRNA Linear Amplification
4.4 miRNA Microarrays
4.5 miRNA qRT-PCR
4.6 miRNA Inhibition
4.7 miRNA Transfection
5. Global miRNA Market Outlook to 2018
5.1 miRNA Tools and Services Market
5.2 By Geography
5.2.1 The Americas
5.2.2 Europe
5.2.3 Asia Pacific (APAC)
6. Ongoing miRNA Research by Disease
6.1 Cancer
6.2 Cardiovascular Diseases
6.3 Metabolic Diseases
6.4 Asthma
6.5 Hepatitis
7. Key Players
7.1 Qiagen
7.2 Sigma-Aldrich Corporation
7.3 Thermo Fisher Scientific Inc.
7.4 Agilent Technologies Inc.
7.5 Life Technologies Corporation
7.6 Affymetrix
7.7 Integrated DNA Technologies
7.8 Exiqon
7.9 Mirus Bio
7.10 Wako Pure Chemical Industries

List of Figures

Figure 3-1: miRNA Biogenesis
Figure 5-1: Global - miRNA Market (Million US$), 2012-2018
Figure 5-2: Global - miRNA Tools Market (Million US$), 2012-2018
Figure 5-3: Global - miRNA Services Market (Million US$), 2012-2018
Figure 5-4: Ongoing miRNA Research by Geography (%), 2013
Figure 5-5: The Americas - miRNA Market (Million US$), 2012-2018
Figure 5-6: The Americas - Ongoing miRNA Research by Disease (%), 2013
Figure 5-7: Europe - miRNA Market (Million US$), 2012-2018
Figure 5-8: Europe - Ongoing miRNA Research by Disease (%), 2013
Figure 5-9: Europe - Ongoing miRNA Research by Country (%), 2013
Figure 5-10: APAC - miRNA Market (Million US$), 2012-2018
Figure 5-11: APAC - Ongoing miRNA Research by Disease (%), 2013
Figure 5-12: APAC - Ongoing miRNA Research by Country (%), 2013
Figure 6-1: Ongoing miRNA Research by Disease (%), 2013
Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013

List of Tables:

Table 4-1: miRNA Purification Products by Supplier
Table 4-2: miRNA Labeling Products by Supplier
Table 4-3: miRNA Linear Amplification Products by Supplier
Table 4-4: miRNA Microarray Products by Supplier
Table 4-5: miRNA qRT-PCR Products by Supplier
Table 4-6: miRNA Inhibition Products by Supplier
Table 4-7: miRNA Transfection Products by Supplier
Table 5-1: The Americas - Ongoing miRNA Research (2013)
Table 5-2: Europe - Ongoing miRNA Research (2013)
Table 5-3: APAC - Ongoing miRNA Research (2013)
Table 6-1: miRNAs Associated with Cancer
Table 6-2: miRNAs Associated with Cardiovascular Diseases
Table 6-3: miRNAs Associated with Metabolic Disorders
Table 6-4: miRNAs Associated with Hepatitis
Table 7-1: Qiagen - miRNA Associated Product Line
Table 7-2: Sigma Aldrich - miRNA Associated Product Line
Table 7-3: Thermo Fisher - miRNA Associated Product Line
Table 7-4: Agilent - miRNA Associated Product Line
Table 7-5: Life Technology - miRNA Associated Product Line
Table 7-6: Affymetrix - miRNA Associated Product Line
Table 7-7: IDT - miRNA Associated Product Line
Table 7-8: Exiqon - miRNA Associated Product Line
Table 7-9: Mirus Bio - miRNA Associated Product Line
Table 7-10: Wako - miRNA Associated Product Line

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.